All In MedTech

FDA Clearance Tracker · P130004-S011

ReSure Sealant

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 2, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 2, 2021

Approved

Time to decision

145 days

Received Jun 10, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130004-S011
Device name
ReSure Sealant
Applicant location
Bedford, MA
Received
Jun 10, 2021
Decided
Nov 2, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P130004

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code PFZ

FDA's approval statement

As written in FDA's record.

Approval for updates to the labeling to include the findings of the Post-Approval Study (PAS) designated as the Retrospective Analysis Study for Endophthalmitis.

Source documents

Other decisions for Ocular Therapeutix, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.